What does 42 CFR Part 2 primarily regulate?

42 CFR Part 2 is a federal regulation that primarily focuses on the confidentiality of substance use disorder patient records. It is designed to protect the privacy of individuals seeking treatment for alcohol and drug-related issues. This regulation ensures that information pertaining to a patient’s substance use treatment is kept confidential and is not disclosed without the patient's consent, except in certain situations specified by the regulation.

The emphasis on confidentiality in this context is crucial, as it encourages individuals to seek help without fear of stigma or repercussions that might arise from their substance use history being disclosed. This regulation plays a vital role in promoting the treatment and recovery of individuals by safeguarding sensitive health information associated with alcohol and drug treatment.

Other options, while relevant to aspects of healthcare, do not align with the primary purpose of 42 CFR Part 2. Patient billing practices pertain to the financial aspect of healthcare, health insurance terms relate to the coverage and administration of health services, and emergency medical procedures focus on immediate medical response protocols—all of which fall outside the scope of confidentiality regarding substance use treatment records that 42 CFR Part 2 specifically addresses.